VRDN Viridian Therapeutics, Inc.
Healthcare$17.24-2.54%ClosedMarket Cap: $1.55B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$38.13
Target (Median)
$36.50
Target Range
$26.00 - $50.00
Upside from current price: 121.2%
Rating Distribution
3 Strong Buy13 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-06 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-05 | Needham | maintain | Buy | Buy |
| 2026-04-21 | Truist Securities | maintain | Buy | Buy |
| 2026-04-08 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-07 | Goldman Sachs | maintain | Buy | Buy |
| 2026-04-02 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-03-31 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-03-31 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-30 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.42 | $244.4M | 11 |
| Sun Dec 31 | $-0.19 | $579.9M | 10 |
| Mon Dec 31 | $1.62 | $856.6M | 4 |
| Tue Dec 31 | $3.04 | $1.13B | 4 |